🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals administering substances of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or prison.

Service Reaction and Content Removal

Based on TikTok, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Online Trading Operations

Research also found groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, positive testimonials and detailed guides for mixing or administering at residence.

Within moments of joining one community, a seller shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Within these groups, messages display dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant health risks”.